TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC.

• B HALL STRATEGIES, LLC $180,000 Outside firm · 7 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

• H.R. 4299
  Protecting Patient Access to Cancer and Complex Therapies Act
  2 filings

• 2026 $90,000 3 filings
• 2025 $90,000 4 filings

• Pharmacy 5
• Medicare/Medicaid 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

• SENATE 6